These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2782741)

  • 1. Twenty isoniazid-associated deaths in one state.
    Moulding TS; Redeker AG; Kanel GC
    Am Rev Respir Dis; 1989 Sep; 140(3):700-5. PubMed ID: 2782741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid-related fatal hepatitis.
    Millard PS; Wilcosky TC; Reade-Christopher SJ; Weber DJ
    West J Med; 1996 Jun; 164(6):486-91. PubMed ID: 8764622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effect other than liver dysfunction in treatment of latent tuberculous infection by isoniazid].
    Ito K; Hoshino H; Nakazono T; Masuyama H; Sugita H; Yoshiyama T; Kato S
    Kekkaku; 2007 Jan; 82(1):1-9. PubMed ID: 17310776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective: preventive isoniazid therapy and the liver.
    Israel HL; Gottlieb JE; Maddrey WC
    Chest; 1992 May; 101(5):1298-301. PubMed ID: 1582287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid hepatitis among pregnant and postpartum Hispanic patients.
    Franks AL; Binkin NJ; Snider DE; Rokaw WM; Becker S
    Public Health Rep; 1989; 104(2):151-5. PubMed ID: 2495549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid preventive therapy for tuberculosis. Decision analysis considering ethnicity and gender.
    Jordan TJ; Lewit EM; Reichman LB
    Am Rev Respir Dis; 1991 Dec; 144(6):1357-60. PubMed ID: 1741549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
    Kopanoff DE; Snider DE; Caras GJ
    Am Rev Respir Dis; 1978 Jun; 117(6):991-1001. PubMed ID: 666111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoniazid-related hepatic failure in children: a survey of liver transplantation centers.
    Wu SS; Chao CS; Vargas JH; Sharp HL; Martín MG; McDiarmid SV; Sinatra FR; Ament ME
    Transplantation; 2007 Jul; 84(2):173-9. PubMed ID: 17667808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe isoniazid-associated hepatitis--New York, 1991-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jul; 42(28):545-7. PubMed ID: 8326947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):536-41. PubMed ID: 1299708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver damage in treatment of latent tuberculous infection by isoniazid].
    Ito K; Hoshino H; Nakazono T; Masuyama H; Sugita H; Yoshiyama T; Kato S
    Kekkaku; 2006 Nov; 81(11):651-60. PubMed ID: 17154043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid-associated hepatitis deaths: a review of available information.
    Snider DE; Caras GJ
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):494-7. PubMed ID: 1736764
    [No Abstract]   [Full Text] [Related]  

  • 16. Isoniazid for the tuberculin reactor: take it or leave it.
    Tsevat J; Taylor WC; Wong JB; Pauker SG
    Am Rev Respir Dis; 1988 Jan; 137(1):215-20. PubMed ID: 3276255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is isoniazid safe for liver transplant candidates with latent tuberculosis?
    Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY
    Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients.
    Byrd RB; Horn BR; Solomon DA; Griggs GA
    JAMA; 1979 Mar; 241(12):1239-41. PubMed ID: 762788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid hepatotoxicity in renal transplant recipients.
    Antony SJ; Ynares C; Dummer JS
    Clin Transplant; 1997 Feb; 11(1):34-7. PubMed ID: 9067692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.